Suven to do phase IV trials for US firm
09 March 2005 | News
Suven Life Sciences has signed a contract with United Therapeutics Corp., USA, for conduct of Phase IV clinical trials on United's product in India. The initial contract is valued at $2.5 million and the 15-months study would be conducted in over 30 institutions in India.
